FdaApplication

NDA 209844

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL PHARMA NDA B2 HOLDINGS
application_typeNDA
approval_date2018-06-15

Products (1)

ProductActive ingredientStrengthDosage form
LYMEPAKDOXYCYCLINE HYCLATEEQ 100MG BASETABLET;ORAL

1 product